Medical devices, healthcare technology and the business of care
PMA approval · P120002

SMA RT CONTROL AND SMART VASCULAR STENT SYSTEMS

Cordis US Corporation · Decision date Nov 7, 2012

MEDTECHLEDGER EXPLANATIONP120002

What did the FDA approve?

FDA approved the S.M.A.R.T. Control and S.M.A.R.T. Vascular Stent Systems on November 7, 2012. The stated purpose is to improve luminal diameter in patients with de novo or restenotic native lesions of the superficial femoral artery and/or proximal popliteal artery, where total lesion length is up to 150 mm and reference vessel diameter ranges from 4 mm to 7 mm.

The decision is an original PMA approval for Cordis US Corporation under product code NIP, classified as a superficial femoral artery stent. The statement reports the device's indicated use; it does not independently establish safety or clinical effectiveness. No supplement type or reason is recorded, so no change to a prior approval is described.

FDA approval order statement

APPROVAL FOR THE S.M.A.R.T. CONTROL AND S.M.A.R.T. VASCULAR STENT SYSTEMS. THIS DEVICE IS INDICATED FOR USE TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF PATIENTS WITH DE NOVO OR RESTENOTIC NATIVE LESION(S) OF THE SUPERFICIAL FEMORAL ARTERY AND/OR PROXIMAL POPLITEAL ARTERY WITH TOTAL LENGTH UP TO 150 MM AND WITH A REFERENCE VESSEL DIAMETER RANGING FROM 4 MM TO 7 MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Nov 7, 2012

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P120002
Regulatory pathway
Premarket approval application
Product code
NIP
Decision code
APPR
Decision date
Nov 7, 2012
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P120002 received

    Application receipt date recorded by FDA.

  2. P120002 · FDA decision

    APPR

  3. P120002/S036 · Related supplement

    S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems; S.M.A.R.T. RADIANZ Vascular Stent System

Timeline entries are records held by MedtechLedger for P120002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120002

Product / regulatory recordCompanyPathwayDecision dateSource
Cordis US CorporationPMA supplementOct 15, 2026FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cordis US Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
14201 NW 60th Ave., Miami Lakes, FL, 33014

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records